摘要:
Compounds of formula (I), and their pharmaceutically acceptable derivatives, wherein R?1 and R2¿ are optional substituents and independently represent C¿1-6? alkyl, C2-6 alkenyl [optionally substituted by CO2H or CO2(C1-6 alkyl)], C2-6 alkynyl, halogen, C1-3 perfluoroalkyl, (CH2)mAr?1, (CH¿2)mHet1, (CH2)mCONR?7R8, (CH¿2)mCO2R8, O(CH¿2?)qCO2R?8, (CH¿2)mCOR8, (CH2)mOR8, O(CH¿2?)pOR?8, (CH¿2)mNR7R8, CO2(CH2)qNR?7R8, (CH¿2)mCN, S(O)nR8, SO2NR7R8, CONH(CH¿2)mAr?1 or CONH(CH¿2?)mHet?1; R3¿ represents H, C¿1-6? alkyl, (CH2)pNR?9R10, SO¿2R10, SO2NR?9R10, (CH¿2)mCOR10, C2-6 alkenyl, C2-6 alkynyl, (CH2)mCONR?9R10, (CH¿2)mCO2R10, (CH2)pCN, (CH2)pR10 or (CH¿2?)pOR?10; R4¿ represents H or C¿1-6? alkyl; R?5¿ represents H or OH; R6 represents phenyl optionally fused to a heterocyclic ring, the group as a whole being optionally substituted; R7-10 are fully defined herein and may independently represent Ar?2 or Het2¿; Z represents CO¿2?H, CONH(tetrazol-5-yl), CONHSO2O(C1-4 alkyl), CO2Ar?3, CO¿2(C1-6 alkyl), tetrazol-5-yl, CONHSO2Ar3, CONHSO¿2?(CH2)qAr?3¿ or CONHSO¿2?(C1-6 alkyl); Ar?1-3¿ independently represent phenyl, naphthyl, or an aromatic heterocycle, which groups are optionally fused and optionally substituted; and Het1 and Het2 independently represent a non-aromatic heterocycle which is optionally substituted; are useful in the treatment of restenosis, renal failure and pulmonary hypertension.
摘要:
The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
摘要:
The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
摘要:
Compounds of formula (I) and their salts, solvates, prodrugs, etc., wherein the substituents have the values mentioned herein, are Procollagen C-Proteinase (PCP) inhibitors and have utility in conditions mediated by PCP.
摘要:
Compounds of formula (I) and their salts, solvates, prodrugs, etc., wherein the substituents have the values mentioned herein, are Procollagen C-Proteinase (PCP) inhibitors and have utility in conditions mediated by PCP.
摘要:
Compounds of formula (I), and their pharmaceutically acceptable derivatives, wherein R?1 and R2¿ are optional substituents and independently represent C¿1-6? alkyl, C2-6 alkenyl [optionally substituted by CO2H or CO2(C1-6 alkyl)], C2-6 alkynyl, halogen, C1-3 perfluoroalkyl, (CH2)mAr?1, (CH¿2)mHet1, (CH2)mCONR?7R8, (CH¿2)mCO2R8, O(CH¿2?)qCO2R?8, (CH¿2)mCOR8, (CH2)mOR8, O(CH¿2?)pOR?8, (CH¿2)mNR7R8, CO2(CH2)qNR?7R8, (CH¿2)mCN, S(O)nR8, SO2NR7R8, CONH(CH¿2)mAr?1 or CONH(CH¿2?)mHet?1; R3¿ represents H, C¿1-6? alkyl, (CH2)pNR?9R10, SO¿2R10, SO2NR?9R10, (CH¿2)mCOR10, C2-6 alkenyl, C2-6 alkynyl, (CH2)mCONR?9R10, (CH¿2)mCO2R10, (CH2)pCN, (CH2)pR10 or (CH¿2?)pOR?10; R4¿ represents H or C¿1-6? alkyl; R?5¿ represents H or OH; R6 represents phenyl optionally fused to a heterocyclic ring, the group as a whole being optionally substituted; R7-10 are fully defined herein and may independently represent Ar?2 or Het2¿; Z represents CO¿2?H, CONH(tetrazol-5-yl), CONHSO2O(C1-4 alkyl), CO2Ar?3, CO¿2(C1-6 alkyl), tetrazol-5-yl, CONHSO2Ar3, CONHSO¿2?(CH2)qAr?3¿ or CONHSO¿2?(C1-6 alkyl); Ar?1-3¿ independently represent phenyl, naphthyl, or an aromatic heterocycle, which groups are optionally fused and optionally substituted; and Het1 and Het2 independently represent a non-aromatic heterocycle which is optionally substituted; are useful in the treatment of restenosis, renal failure and pulmonary hypertension.
摘要:
The invention relates to compounds of Formula (1 ) and to intermediates in the preparation of, compositions containing and uses of such derivatives. The compounds according to the present invention are β2 adrenergic receptor agonists and M3 muscarine receptor antagonists useful in numerous diseases, disorder and conditions, in particular inflammatory, allergic and respiratory diseases, disorder and conditions.
摘要:
This invention relates to the hydrochloride salt of 5-[3-{3-hydroxyphenoxy)azetidin-1-yl]-5- methyl-2,2-diphenylhexanamide or derived form thereof and its use as a medicament.
摘要:
This invention relates to the hydrochloride salt of 5-[3-{3-hydroxyphenoxy)azetidin-1-yl]-5- methyl-2,2-diphenylhexanamide or derived form thereof and its use as a medicament.